Grace Therapeutics, Inc. - GRCE
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Feb 17, 2026 | SCHEDULE 13G/A | ADAR1 Capital Management, LLC | 9.9% | 1,646,173 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | ADAR1 Capital Management GP, LLC | 9.9% | 1,648,791 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Daniel Schneeberger | 9.9% | 1,646,173 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | Nantahala Capital Management, LLC | 9.99% | 1,586,659 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | Wilmot B. Harkey | 9.99% | 1,586,659 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | Daniel Mack | 9.99% | 1,586,659 | View |
| Jan 28, 2026 | SCHEDULE 13G/A | Orin Hirschman | 5.9% | 907,217 | View |
| Jan 28, 2026 | SCHEDULE 13G/A | AIGH Capital Management LLC | 5.9% | 907,217 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | ADAR1 Capital Management, LLC | 9.9% | 1,529,200 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | ADAR1 Capital Management GP, LLC | 9.9% | 1,534,254 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Daniel Schneeberger | 9.9% | 1,529,200 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.